Rawlings P. Datir
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Journal: Nature
Published: July 21, 2022
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.
Journal: Nature
Published: July 21, 2022
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity.
Journal: Cell reports
Published: May 06, 2022
Disengagement From HIV Care and Failure of Second-Line Therapy in Nigeria: A Retrospective Cohort Study, 2005-2017.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: July 22, 2021
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
Journal: The Journal of infectious diseases
Published: July 12, 2021
Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.
Journal: The Journal of antimicrobial chemotherapy
Published: June 23, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Journal: Nature
Published: June 18, 2021
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Journal: Nature
Published: April 16, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies.
Journal: medRxiv : the preprint server for health sciences
Published: February 23, 2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Journal: Cell reports
Published: February 03, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Journal: Nature
Published: January 26, 2021
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.
Journal: medRxiv : the preprint server for health sciences
Published: January 05, 2021
Last Updated: 09/26/2026